Business Description

Description
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 66.79
Equity-to-Asset 0.68
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -8.16
Distress
Grey
Safe
Beneish M-Score -1.12
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 0.2
3-Year FCF Growth Rate 5.1
3-Year Book Growth Rate 98.4

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -8.28
12-1 Month Momentum % -40.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.1
Quick Ratio 3.63
Cash Ratio 3.23
Days Inventory 368.74
Days Sales Outstanding 6
Days Payable 578.58

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 12
Shareholder Yield % -152.08
Name Current Vs Industry Vs History
Gross Margin % 76.28
Operating Margin % -200.52
Net Margin % -177.91
FCF Margin % -270.02
ROE % -84.62
ROA % -48.51
ROIC % -77.35
ROC (Joel Greenblatt) % -8866.67
ROCE % -76.87

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.16
PB Ratio 0.13
EV-to-EBIT 0.23
EV-to-EBITDA 0.25
EV-to-Revenue -0.46
EV-to-FCF 0.22
Earnings Yield (Greenblatt) % 434.78
FCF Yield % -160.1

Financials

SPRCY's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:SPRCY

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

SciSparc Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 3.319
EPS (TTM) ($) 0
Beta 0
Volatility % 104.99
14-Day RSI 0
14-Day ATR ($) 0.614421
20-Day SMA ($) 0
12-1 Month Momentum % -40.62
52-Week Range ($) 2.75 - 12.249755
Shares Outstanding (Mil) 2.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

SciSparc Ltd Filings

Filing Date Document Date Form
No Filing Data

SciSparc Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

SciSparc Ltd Frequently Asked Questions

What is SciSparc Ltd(SPRCY)'s stock price today?
The current price of SPRCY is $4.00. The 52 week high of SPRCY is $12.25 and 52 week low is $2.75.
When is next earnings date of SciSparc Ltd(SPRCY)?
The next earnings date of SciSparc Ltd(SPRCY) is .
Does SciSparc Ltd(SPRCY) pay dividends? If so, how much?
SciSparc Ltd(SPRCY) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1